Compare ICICI Prudential Nifty Pharma Index Fund vs Nippon India Pharma Fund
Risk
Very High
Very High
Rating
2.0
3.0
Min SIP Amount
₹1000
₹100
Expense Ratio
1.02
1.81
NAV
₹17.42
₹510.69
Fund Started
25 Nov 2022
10 May 2004
Fund Size
₹91.88 Cr
₹7875.40 Cr
Exit Load
-
Exit load of 1% if redeemed within 1 month.
1 Year
12.11%
9.01%
3 Year
23.81%
23.77%
5 Year
-
15.54%
Equity
100.35%
98.96%
Cash
-0.35%
1.04%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 21.38% |
Divi's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 9.40% |
Lupin Ltd. | 6.61% |
Torrent Pharmaceuticals Ltd. | 5.24% |
Laurus Labs Ltd. | 4.75% |
Aurobindo Pharma Ltd. | 4.28% |
Alkem Laboratories Ltd. | 4.21% |
Glenmark Pharmaceuticals Ltd. | 3.84% |
Sun Pharmaceutical Industries Ltd. | 12.67% |
Lupin Ltd. | 7.88% |
Divi's Laboratories Ltd. | 6.54% |
Dr. Reddy's Laboratories Ltd. | 6.06% |
Cipla Ltd. | 5.88% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Medplus Health Services Ltd. | 3.68% |
Vijaya Diagnostic Centre Ltd. | 3.51% |
Ajanta Pharma Ltd. | 3.39% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.78% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Launch Date
25 Nov 2022
10 May 2004
